TARSUS PHARMACEUTICALS INC.
TARS
|
|
| |
|
| Trading Volume | 17,656 |
|
|
39.22 - 12.98 |
| Market Cap Full | $ 0.9B |
Quarterly +
| 2026 | 2025 | 2024 | 2023 | |
|---|---|---|---|---|
| Q1 | 19.3% | 0.4% | 79.3% | -14.3% |
| Q2 | - | -16.5% | -30% | 43.8% |
| Q3 | - | -16.5% | 13.1% | -1.7% |
| Q4 | - | -16.5% | 9.2% | 16.1% |
Monthly +
| J | F | M | A | M | J | J | A | S | O | N | D |
| 2026 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | - | - | - | - |
| 2025 | |||||||||||
| 0.4 | - | - | - | - | - | - | - | - | - | - | - |
| 2024 | |||||||||||
| 34.5 | 40.3 | -5 | -10.8 | 1.9 | -23.7 | -3.7 | 13.1 | - | - | - | - |
| 2023 | |||||||||||
| 7.5 | -1.7 | -18.9 | 18.7 | 12.3 | 7.9 | 21.8 | -20.5 | 1.5 | -19.9 | 16.1 | 22.5 |
| 2022 | |||||||||||
| -14.4 | -12.2 | -4.6 | 8.9 | -24.9 | 6.2 | 2.9 | -2.8 | 17.3 | 7.6 | -8.7 | -12.8 |
| 2021 | |||||||||||
| -8.8 | -3.9 | -11.9 | -3.9 | 8.5 | -13 | -20.6 | 15.2 | -18.7 | 28.8 | -4.2 | -11.8 |
EPS
| 2023 | 2022 | 2021 | |
|---|---|---|---|
| Q1 | -0.9 | -1 | 0.5 |
| Q2 | -1.2 | -0.2 | 0.3 |
| Q3 | -1.3 | -0.8 | -0.8 |
| Q4 | 0 | -0.5 | -0.7 |
| A | -3.33 | -2.5 | -0.7 |